|1. Cross-cultural validation of patient-reported outcome (PRO) measurements: challenges and solutions|
|By Juhee Cho & Danbee Kang|
|Biography|| Dr. Cho is a trained behavior scientist and epidemiologist. Her primary research interests are the psycho-social problems caused by cancer and its treatment. Dr. Cho is leading several qualitative and quantitative observational studies and clinical trials to find out the needs of cancer patients and their families, as well as to develop and implement the education programs both in clinic and in communities. As part of her work, she has had to develop or validate a variety of measuring tools for survivorship and health-related quality of life for cancer survivors in Korea and other Asian countries.
Dr. Kang is a trained behavior scientist and clinical epidemiologist. Her primary research interests are the psycho-social problems caused by chronic disease. Dr. Kang is conducting several quantitative observational studies and clinical trials to find out the vulnerable patients and to generate clinical evidences using statistic methods. As part of her work, she has had to develop or validate a variety of measuring tools as well as to measure patient reported health using the developed tools.
|Room||I (2nd floor)|
|Target||researchers, clinicians, nurses who are plan to validate English version of patient-reported outcomes or quality of life measures into their own languages and use them for clinical and research settings|
|Abstract||Now-a-days there is significant discussion about patient-reported outcomes (PRO) in medical world. There are a number of novel PRO measures through its therapeutic area working groups and clinical trial sponsors (e.g., pharmaceutical firms) seeking to use these newly developed PRO measures frequently require translation and cultural adaptation of the tools for use in global clinical development programs, which together with cognitive interviewing of the resulting translations is known as linguistic validation (LV). The workshop will begin with updating the recent trends of PRO, important concepts for understanding of PRO, significance, ideal properties, types, development and evaluation of PRO instruments. Then we will introduce the rationale and goals of the PRO instruments (measures) translation and LV process using actual examples including PRO-CTCAE and PRPMIS translation from English to Korea. Furthermore, we will introduce methods for quantitative (psychometric) validation.|
|2. Couple Counselling as a Part of Psycho-Social Care in Oncology|
|By Marta I. Porebiak|
|Biography||Marta I. Porebiak, Ph.D. is a clinical psychologist, certified EU psychotherapist (EAP), Polish certified psycho-oncology supervisor (PTPO), an assistant professor at SWPS University of Social Sciences and Humanities in Warsaw, Poland. She is an author of various articles and handbook chapters for psychologists and medical doctors, as well as a presenter at national and international congresses. Among her areas of expertise are individual psychodynamic therapy, systemic family and couple therapy, crisis management in psycho-oncology and palliative care. She runs a psychotherapy private practice and she collaborates with Polish Medical Association and European School of Oncology (ESO) as an instructor.|
|Room||J (2nd floor)|
|Target||clinicians, psychologists, nurses, social workers|
|Abstract||Cancer affects not only individuals but their close ones as well. It’s a common picture to observe patients accompanied by their spouse, parent, adult child, sibling or friend to medical appointments and treatment procedures. Providing psycho-social care in the presence of another person could be challenging, therefore we need to consider some guidelines for couple consultations. Our patient is no longer an individual, but both of them are in a need of counseling. A close person could be a great source of information for the clinician, but also a valuable support resource for the cancer patient. Remembering, that caregivers usually also benefit from psycho-social counseling. During the workshop, participants learn how to apply the Systemic Approach in consulting couples. We will practice interviewing techniques, tailored for couple consultations, building therapeutic contact, dividing our attention, and strengthening mutual empathy using circularity. The workshop is especially recommended for clinicians, psychologists, social workers and nurses who want to start consulting couples, or who want to better their counseling skills in delivering joint consultations.|
|4. Demoralization in cancer care: diagnosis and treatment|
|By David Kissane, Anja Mehnert-Theuerkauf, Luigi Grassi, Chun-Kai Fang, Sigrun Vehling & Rebecca Philipp|
|Biography||David W. Kissane, AC MD, is a psychiatrist and researcher in psycho-oncology and palliative care. He is currently the Chair of Palliative Medicine Research at The University of Notre Dame Australia, Emeritus Professor of Psychiatry at Monash University, and previously Chairman of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center in New York. His academic interests include group, couples and family psychotherapy trials, communication skills training, studies of existential distress, and ethics of end-of-life care. He chaired the IPOS World Congress in 2000, and was awarded their Arthur Sutherland Award for lifetime achievement in 2008.
Anja Mehnert-Theuerkauf, PhD, is Professor of Medical Psychology and Medical Sociology at the University of Leipzig in Germany. Her academic interests include studies of mental disorders and distress in cancer including demoralization and loss of meaning, and psychotherapy trials for patients with cancer. She has published over 200 peer-reviewed papers, several books and holds editorial positions for journals such as Psycho-Oncology and Journal of Cancer Survivorship. Anja Mehnert was awarded the Hiroomi Kawano New Investigator Award by IPOS in 2009, the German Cancer Award in 2016 for Psycho-oncology, and she chaired the IPOS World Congress in Berlin in 2017.
Luigi Grassi MD MPhil, is Professor and Chair of Psychiatry, Department of Biomedical Sciences, University of Ferrara, Ferrara, Italy. He is Head of the University Unit of Hospital Psychiatry, S. Anna Hospital and Local Health Agency in Ferrara. He is author of over 200 scientific papers, chapters of books and books. He has been the President of the International Psycho-Oncology Society (2006-2008) and the Italian Society of Psycho-Oncology (2003-2011). He is currently Chair of the IPOS Federation of Psycho-Oncology Societies and the World Psychiatric Association - Section on Psycho-Oncology & Palliative Care.
Chun-Kai Fang, MD PhD is Chief of the Department of Psychiatry at the McKay Memorial Hospital in Taiwan, as well as Chief of Taiwan’s Hospice and Palliative Care Centre at McKay Hospital. He is an Assistant Professor in the Department of Medicine and Department of Thanatology and Health Counselling at the National Taipei University of Nursing Health Sciences. Dr Fang translated the Demoralization Scale into Mandarin and has examined the way that demoralization mediates suicidal thinking. He has been President of the Taiwanese Psycho-Oncology Society and IPOS honoured his clinical leadership with its Noemi Fisman Award in 2017.
Sigrun Vehling, PhD, is a researcher at the University Medical Centre Hamburg-Eppendorf, Germany, and works in the Department of Medical Psychology. She has been the principal investigator of a longitudinal study investigating sources of meaning, meaning-focused coping and positive and negative life change in patients with cancer. She has focused on existential issues in cancer, specifically demoralization, sense of dignity and meaning-focused coping. She has been the co-editor of a Psycho-Oncology special issue on the topic of existential distress and she is an active contributor to the IPOS Early Career Special Interest Group.
Rebecca Philipp MSc, PhD, is a researcher in the Department of Medical Psychology, University Hospital Hamburg-Eppendorf Institute and Polyclinic for Medical Psychology, Hamburg, Germany. She has explored the contribution of early experiences that generate attachment security and social relatedness as predictors of building resilience or risk to develop demoralization when events and illness bring challenges to coping later in life.
|Room||Room 501 (5th floor)|
|Target||Psychologists, social workers, nurses, psychiatrists, palliative care clinicians, oncologists, surgeons, and other allied health clinicians|
|Abstract||Demoralization is a clinical state of low morale and poor coping, characterized by hopelessness / helplessness, meaninglessness / loss of purpose, feeling of entrapment, and potential desire to suicide. Systematic reviews show a prevalence of 15% among oncology patients, rising to 30% in palliative care. The risk of suicide points to its clinical importance. Factors associated with its development include medical and mental illness with poor symptom control and disease burden; single status with isolation, alienation or poor social support; female gender; and poor cancer control, with worsening frailty and poor quality of life. Factors protective against its development include being married and supported; employed and a sense of meaning in life; spiritual or religious wellbeing; and personal autonomy and control over life. Clinicians need to assess the value of life, recognize when a sense of pointlessness starts to emerge, and ambivalence about the wish to die. Demoralization can be managed with cognitively-oriented, supportive and meaning-centered therapies, while also treating co-morbid anxiety and depression, and optimizing physical symptom control. Demoralization can be fitted into DSM-5 as a ‘specifier’ for Adjustment or Major Depressive Disorders, or conceptualized within ICD-11 as providing essential phenomena for the poor coping that characterizes Adjustment Disorder|
|5. Integrative Model of Cancer Experience in Children and Teenagers through the use of Art|
|By Olimpia Petzold Rodriguez|
|Biography||Clinical Psychologist, Master degree in Clinical Psychology, Master degree in Neuroscience. PhD candidate assigned at the Psychosomatic and Psycho-Oncology Research Unit of the Université Libre de Bruxelles, Belgium. Her research activities focus on the study of evaluation and treatment of psychological factors in cancer patients, through the use of Art Therapy in young populations. For more than 18 years, she served as professor at the Department of Psycho-socio-anthropology at the University of Zulia, Venezuela. She leads the Spanish Support Group and the HEART (Healing Art) program at CANOPY (Survivorship Center) at Memorial Hermann Hospital, The Woodlands, USA. For her work she was awarded as a 2019 Women of Distinction Honoree by the Montgomery County Women's Council in The Woodlands, US.|
|Room||Room 509 (5th floor)|
|Target||Researchers, Clinicians, Psychologists, and Psychiatrists in the field of Pediatric Psychos-oncology|
|Abstract||The purpose of this interactive activity is to show an integrative model of cancer experience in children and teenagers with cancer through the use of art. The model includes both, the health-improving factors and health deteriorating factors for this age group. It employs a variety of learning modalities, such as team exercises, examples case, inter/intrapersonal activities and experimentation with some art media. During the workshop, the participants will know the dimensions (cognitive, emotional, behavioral, and social) proposed in this model. They will know the basic steps to follow in an art-based assessment session using as reference an art therapy program research developed at Pediatric Specialties Hospital in Venezuela for cancer patients. This research was awarded with the Interamerican Post-graduate Research Award 2019 by the Interamerican Society of Psychology. At the same time, participants will have a close approach to different arts technics such as drawing, painting, modeling, writing a story, and collage used to evaluate the needs and the experience of disease in children and teenagers with cancer. Finally, participants will learn that art may be used as an evaluation tool that employs images to facilitate communication in the therapeutic setting, improving both the assessment and intervention.|
|Organizer||IPOS Early Career Professionals in Psycho-Oncology (ECPP) committee *They will announce or answer about this workshop.|
|Room||Room 554 (5th floor)|
|Description||The goal of the workshop is to foster Early Career Researchers (ECRs) in grant development and research conceptualization. The aim is to provide a supportive environment for intensive development on study design and methods, and gain advice and input from experts at the end of the workshop. ECPPs would present a 5-minute pitch on their proposed research and the expert panel critique it– perhaps an ECPP and Research Committee joint venture. Depending on whether this would be a half-day workshop or lunch event will influence the format and content.|
|8. ACT – An Introduction into Acceptance and Commitment Therapy in Cancer Patients|
|By Gregor Weissflog & Helge Danker|
|Biography||Dr Gregor Weissflog is a clinical psychologist at the University Medical Center Leipzig, Germany. Gregor´s main fields of interest are "Psychosocial Interventions in Oncology", especially Acceptance and Commitment Therapy and "Cancer and Partnership" including dyadic coping.
Dr Helge Danker is a clinical psychologist. He works at the Cancer Counseling Center, University Medical Center, Leipzig, Germany. Helge´s main areas of work are psychotherapy and chronic illness, counseling cancer patients and families, and further education and training of experts from psycho-social professions.
|Room||J (2nd floor)|
|Target||Psychologists, nurses, doctors, counsellors|
|Abstract||The overall aim of the workshop is to give an overview about the Acceptance and Commitment Therapy (ACT). Therefore, the ACT Hexaflex model including its core processes is briefly presented. ACT assumes that a significant part of human suffering is caused by the unwillingness to experience unwanted thoughts, feelings and physical states (experiential avoidance). Workshop participants should learn to support patients to distinguish between what they can change and what is currently unalterable for them. In this context, the workshop also has some specific goals: (1) To put patients in the state of "creative hopelessness". (2) To help patients to differentiate between primary and secondary suffering, to accept primary suffering and to recognize and release secondary suffering. (3) To help patients to distance themselves from self-injurious language and thought patterns. (4) To help patients to experience a kind of self that is not linked to what we think about how we should be. (5) To help patients to know their own values, to formulate related goals and to act committed on these goals in everyday life. (6) Get to know and try out metaphors and experience-oriented exercises.|
|9. CBT for People with Cancer|
|By Stirling Moorey|
|Biography||Stirling Moorey is a consultant psychiatrist and CBT therapist. He is co-author with Dr Steven Greer of The Oxford Guide to CBT for People with Cancer and has contributed to RCTs in CBT in both early and advanced disease. He has over 30 years experience of training mental health professionals in CBT and has worked closely with Drs Kath Mannix and Nigel Sage to develop ‘First Aid CBT’ – an approach that health professionals in oncology and palliative care can use in their everyday practice to manage patients’ psychological distress.|
|Room||K (2nd floor)|
|Target||Psychologists, psychiatrists, social workers, mental health nurses, and health professional with an interest in psychological therapy|
|Abstract||This workshop will introduce a model for understanding the challenges faced by people with life threatening illness from a cognitive perspective. It will describe how the appraisal of the threat to life and the threat to self concept (through the physical, emotional and interpersonal impact of the disease and treatment) is shaped by past experience and underlying beliefs. For those unfamiliar with CBT a simple way to conceptualise patients’ distress will be introduced and some methods for breaking unhelpful patterns of thinking and behaving will be described. Participants will have the opportunity to conceptualise their cases and consider brief interventions to use in the oncology setting. For those with more experience of CBT there will be opportunities to discuss their cases and how to manage challenges.|
|10. How to run a family meeting|
|By David Kissane|
|Biography||Prof David Kissane AC, MD, MPM, FRANZCP, FAChPM, FACLP is an academic psychiatrist and researcher in the fields of psycho-oncology and palliative care. He is currently the Chair of Palliative Medicine Research at the University of Notre Dame Australia, Emeritus Professor of Psychiatry for Monash University, previously Chairman of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center in New York and, before that, the Foundation Chair of Palliative Medicine at the University of Melbourne. His academic interests include group, couples and family psychotherapy trials, communication skills training, studies of existential distress, and the ethics of end-of-life care. He is best known for his model of family therapy delivered to ‘at risk’ families during palliative care, which prevents complicated grief in bereavement. His work on demoralization as a variation of depression in the medically ill has preceded interventions to promote meaning-based coping. His books include Bereavement Care for Families with Routledge (2014), Handbook of Psychotherapy in Cancer Care with Wiley-Blackwell (2011), Oxford Textbook of Communication in Oncology and Palliative Care, Second Edition (2017), Depression and Cancer for the World Psychiatric Association/Wiley (2011) and Family Focused Grief Therapy with Open University Press (2002, 2008).|
|Room||Room 501 (5th floor)|
|Target||Physicians, Social Workers, Psychologists, Nurses, Psychiatrists and any clinicians contributing to the conduct of a family meeting|
|Abstract||Family meetings play a significant role in cancer care, where family support for planning and continuing care is vital to optimize patient care. Health care professionals have generally received little training about how to conduct a family meeting. A schema for running a routine family meeting will be presented. The differing medical and psychosocial agendas will be integrated into a model readily co-facilitated by these respective disciplines. Specific communication techniques enhance the conduct of family meetings. Agenda setting, the use of circular questions and integrative summaries assist the most difficult of families considered at risk of morbid outcomes.|
|11. Group interventions targeting executive functions and decision-making in survivors of non-CNS cancer|
|By Ayala Bloch & Limor Sharoni|
|Biography||Ayala Bloch is a senior neuropsychologist and clinical supervisor with a specialization in Rehabilitation Psychology and a Ph.D. in Neuroscience. She is on the faculty of the Ariel University Graduate Degree Program in Psychology and CEO of the Israeli National Institute for the Rehabilitation of the Brain Injured, where 500 patients with acquired brain damage are treated annually. Previously, Dr. Bloch was Head Psychologist at the Sheba Medical Center Neurological Rehabilitation Department and manager of an advanced cognitive psychology lab at Bar-Ilan University. She has been Head of the Israeli Ministry of Health Professional Committee for Rehabilitation Psychology since 2017.
Limor Sharoni holds a master’s degree in Clinical Neuropsychology from the Hebrew University of Jerusalem, Israel. She is a senior rehabilitation psychologist and neuropsychologist at The National Institute for the Rehabilitation of the Brain Injured, a public NPO dedicated to neuropsychological and psychosocial rehabilitation of individuals with brain damage. Limor established the Gesher-Galilee Center, which provides comprehensive neurorehabilitation and psychotherapy for a diverse population following acquired brain damage, PTSD, and other chronic diseases. Her main interests include neuropsychological, cognitive, and neuro-psycho-oncological rehabilitation; treatment of co-morbid TBI and PTSD; occupational assessment; and counseling for people with acute and chronic medical conditions.
|Room||Room 509 (5th floor)|
|Target||Psycho-oncologists, medical and rehabilitation psychologists, neuropsychologists, occupational therapists, social workers, physicians involved in psycho-oncology|
|Abstract||This half-day workshop aims to familiarize participants with a group intervention method targeting decision-making and other executive functions following non-CNS cancer. The method was developed based on long-standing, effective interventions for acquired brain damage and is now employed in a holistic vocational rehabilitation day program addressing neuropsychological sequelae of disease and treatment in survivors. Deficits in executive functions, the most complex components of human behavior, are among the cognitive impairments most commonly reported following cancer. Their significant effects on vocational and everyday functioning make them an important target in rehabilitation. The workshop will provide background knowledge about executive functions, including decision-making, before exposing participants to the two stages of the intervention, the first addressing executive functioning in general and the second focusing on decision-making. Participants will learn and practice structured strategies for use in individual and group settings, which address collection, monitoring, synthesis, and analysis of information, as well as approaches to and common mistakes in decision-making. The workshop will employ experiential methods, including group decision-making simulations. We will conclude by presenting and discussing the projects of rehabilitation program participants who recently completed the two-stage intervention, which serve as tangible examples of the cognitive processes and skills it facilitates.|
|12. Expressive Arts Therapy Interventions for relieving emotional and physical suffering in Cancer patients|
|By Peter Mai|
|Biography||Peter Mai, MD MA has been establishing a psycho-oncology service at his psychiatric practice in Zurich after resigning from his position as leading consultant at a regional Hospital and psychiatric services near the capital Berne, Switzerland. After having specialized in psychotherapy, psychosomatics and psycho-oncology, he became fascinated by the healing resources of the creative process and arts and studied expressive arts at Tamalpa Institute,N.California (Anna Halprin, Daria Halprin) and art therapy at the IKT Munich (G. Schottenloher),Institute of Art and Therapy, Germany, using expressive art therapy as an integral part of his clinical work and has been teaching expressive arts interventions internationally.|
|Room||Room 554 (5th floor)|
|Target||Clinical psychologists, art therapists, psychiatrists, social workers, chaplains, nurses, oncologists, palliative care and hospice clinicians, medical students, psychology students, physicians in training (Psychiatry trainees/fellows; palliative care trainees/fellows, oncology trainees/fellows). This workshop would also be of interest to researchers of all disciplines who are interested in intervention development in psycho-oncology and palliative care and of artists and therapists who want to expand their understanding of the creative process as a healing process.|
|Abstract||This half day workshop will be divided into three parts: 1) an overview of the most useful application of art therapy interventions for patients with cancer ; 2) some clinical case presentations will show the effects of the creative process on a physical, emotional and spiritual level: attendees will be introduced to the topics of “autonomy control”, “intermodal transfer” and the “decentering process” of art interventions 3) during the experiential part of the workshop, the attendees will be introduced to different arts modalities in order to recognize the therapeutic impact of specific art interventions and to initiate their own dialogue between life experience and creative expression.|
|13. Flourishing at work: A mindful practice workshop for health professionals and researchers|
|By Ronald Epstein & Daisuke Fujisawa|
|Biography||Ronald Epstein MD has conducted groundbreaking research into communication in medical settings and developed innovative educational programs that promote mindfulness, communication and self-awareness. Dr. Epstein co-directs the Center for Communication and Disparities Research and Mindful Practice Programs at the University of Rochester, where he is Professor of Family Medicine, Oncology and Palliative Care. A graduate of Harvard Medical School, he has received numerous humanism awards and fellowships, and the American Cancer Society’s highest award, the Clinical Research Professorship. He has authored over 300 articles and chapters. His first book, Attending: Medicine, Mindfulness and Humanity, was released in 2017.
Dr. Daisuke Fujisawa is a psychiatrist and an associate professor in psychiatry and patient Safety in Keio University School of Medicine, Japan. He is one of the former board directors of IPOS.
|Room||Room 555 (5th floor)|
|Target||Health professionals of any discipline|
|Abstract||Health professionals caring for the seriously ill face important cognitive and emotional challenges that extend them beyond the skills and knowledge in formal training and require self-awareness, emotional intelligence, teamwork and shared mind. For the past twenty years, Dr Epstein has written, researched and developed educational programs in mindful practice that have been disseminated worldwide. With the publication of “Mindful Practice” in the Journal of the American Medical Association in 1999, Dr. Epstein has become the leading voice in medicine advocating mindful practice as a way to cultivate attentiveness, curiosity, beginner’s mind and presence, attributes that can contribute to improved relationships between health professionals, patients and families, improved understanding of cognitive and emotional factors that affect communication and decision making, and health professionals’ ability to care for themselves, avoid burnout and flourish in practice. In this workshop, Dr. Epstein will discuss four aspects of mindfulness relevant to health professionals that can affect the technical, cognitive and emotional competencies for clinicians caring for those with serious illness, as well as summarize recent research suggesting means whereby health professionals can become more mindful and be more effective clinically, form stronger relationships with patients and colleagues, and address clinician burnout and moral distress. Dr. Epstein will offer an experiential and participatory session that would introduce participants to three important approaches to promoting mindfulness in clinical settings: contemplative practices, sharing of narratives about meaningful and challenging experiences in the work setting, and using an appreciative inquiry approach to addressing complex challenges in the workplace. It will be geared for health professionals and researchers. The workshop will be primary experiential, with some conceptual models and data. Dr. Fujisawa is a psychiatrist and clinical researcher who has been applying mindfulness-based approaches to cancer care and to self-care of health professionals. He has conducted randomized controlled trials in this field. He is the current co-chair of IPOS membership committee and one of the past board directors of IPOS. This workshop will be led primarily by Dr. Epstein, moderated by Dr. Fujisawa.|
|14. Managing Cancer and Living Meaningfully (CALM) Workshop|
|By Gary Rodin & Sarah Hales|
|Biography||Gary Rodin, MD, FRCPC. Gary Rodin is the Joint University of Toronto/University Health Network Harold and Shirley Lederman Chair in Psychosocial Oncology and Palliative Care and is Head of the Department of Supportive Care at the Princess Margaret Cancer Centre in Toronto, Canada. Dr. Rodin is the Director of the Global Institute of Psychosocial, Palliative and End-of-Life Care (GIPPEC) and a Professor of Psychiatry at the University of Toronto. He is a clinician-investigator who has published widely on the psychiatric and psychosocial aspects of cancer and other medical illnesses. Under his leadership, the Psychosocial Oncology and Palliative Care Program at the Princess Margaret has achieved an international reputation for its academic and clinical excellence. Dr. Rodin has authored texts on Depression in the Medically Ill and is currently leading research on the psychological impact of advanced and terminal disease in affected patients and their families.
Sarah Hales, MD, PhD, FRCPC. Sarah Hales is a psychiatrist for the Division of Psychosocial Oncology in the Department of Supportive Care at the Princess Margaret Cancer Centre in Toronto. Her research has been funded by both the Canadian Cancer Society and the Canadian Institutes of Health Research. Her clinical and research interests include the end of life experience as it affects both patients and families, and psychotherapeutic interventions aimed at alleviating distress in those facing advanced disease.
|Room||C-1 (1st floor)|
|Target||Psychologists, psychiatrists, psychotherapists, social workers, nurses, physicians and other allied health professionals working in oncology|
|Abstract||Managing Cancer And Living Meaningfully (CALM) is a brief, manualized, evidence-based psychotherapeutic intervention uniquely tailored to reduce or prevent distress in individuals with advanced or metastatic cancer and their families. It consists of 3-6 psychotherapeutic sessions delivered over 6 months and has been shown to reduce distress and increase well-being in this population. The morning of the workshop will consist of two streams: 1. Introductory: Formal lectures and video-recordings of real psychotherapeutic sessions will be used to teach the theoretical foundations, therapeutic process, and content domains of CALM 2. Advanced (for participants with prior exposure to CALM): Focus on theoretical issues, refinement of techniques, and skills to teach and supervise other CALM therapists.
The afternoon session will integrate theory, research, and the clinical application of CALM. Participants will have the opportunity to reflect on the day, provide feedback, and contribute to an open discussion about future CALM cases in their settings.
|15. Navigating through Life Adversities with “Kindfulness”: The Theory and Practice of Self-Compassion for Healthcare Professionals in Cancer Care|
|By Adrian H.Y. Wan|
|Biography||Dr. Adrian H.Y. Wan is a post-doctoral fellow at the Centre on Behavioral Health, The University of Hong Kong. He is a scientist-practitioner in the field of mental health and mindfulness intervention. His research interests lie in psycho-oncology, holistic healthcare for cancer survivors and families, professional burnout, emotion regulation, and coping with physical and psychological traumas. He was presented with the Young Investigator Award at the Hong Kong International Cancer Congress in 2009. Dr. Wan is a pioneer in the research of applying mindful self-compassion in cancer care, and a seasoned trainer in holistic health practices.|
|Room||C-2 (1st floor)|
|Target||Health professionals of all disciplines who work in psychosocial oncology and/ or palliative care. The workshop will be of value for those who seeks to acquire better understanding of the application of self-compassion in cancer care, and those who wish to cultivate spiritual resources to help them better manage compassion fatigue.|
|Abstract||Self-compassion is at the heart of altruistic, compassionate, and person-centered healthcare service; it is also the antidote to human suffering and compassionate fatigue among helping professionals. Over the decade, research has consistently shown the benefits of self-compassion on psychological well-being, such as improving quality of life, enhancing resilience, betterment in emotion regulation, and cultivating positive affectivity. The practice of self-compassion was found effective in enhancing psychosocial wellness of college and university students, allied health professionals, as well as individuals suffering from depression, diabetes, eating disorder, PTSD, stress-related issues, and people with chronic medical conditions, including cancer survivors. Despite its Buddhist origin, self-compassion can be learnt by anyone regardless of their age, gender, religious orientations, and social status. This one-day experiential workshop provides an overview of theory and practice of self-compassion for practitioners in the cancer care profession. The workshop is not only a platform to learn the selected self-compassion which can be adapted for cancer patients (and their family members), but also an experiential opportunity for healthcare professionals to relax, recharge, and reconnect with their professional goals as ways to protect against caregiver fatigue..|
|16. How to start your research|
|By Christoffer Johansen|
|Biography||I initiated, established and headed the first department of psychosocial oncology applying epidemiological methods at the Danish Cancer Society Research Center. The research aimed at evaluating how the mind may cause cancer, the effect of a cancer disease on psychosocial outcomes and interventions to improve psychosocial outcomes in cancer survivors. In parallel I worked within electromagnetic fields and health risks as well as genetics in glioma. I am currently heading cancer late effect research in Copenhagen. All my 498 (October 2019) peer reviewed publications may be seen at My Bibliography, NCBI – at this URL: http://www.ncbi.nlm.nih.gov/sites/myncbi/1HozijIyO-BQx/bibliography/48107638/public/?sort=date&direction=ascending|
|Room||F (1st floor)|
|Target||Young, ambitious clinicians – any kind or education, who wants to start their scientific career|
|Abstract||Why do research? What is science? What is the purpose and how do I begin? These basic questions always need a response. In this short workshop I will introduce you to basic psychosocial cancer research and illustrate my opinions with examples from cohort, case-control, cross-sectional, ecological and other types of studies. I am not an expert, but I have been in the field for 30 years and tried to get an idea, raise funding, conduct the study, analyze the data, write the paper and have it published in a peer-reviewed journal. Together we will establish a recipe for getting started. I will also talk about paper writing, not being English but a Dane struggling with the English language. I am trying to teach you how important content is, content being knowledge in your field, ability to discuss a study, ability to see the strengths and limitations of a given study. I look for the fun in science, the academic surplus, the joy that science provide you with when you marry this wonderful person….|
|17. Communication and Challenging Discussions at the End of Life|
|By Darius Razavi|
|Biography||Darius Razavi, M.D., Ph.D., is psychiatrist, Professor of Psycho-oncology at the “Université Libre de Bruxelles” and Director of the “Psycho-oncology Clinic” of Jules Bordet Institute, Cancer Center of the Université Libre de Bruxelles (Belgium). His main research interest is psycho-oncology (funded by the FNRS). His research focus on the screening and management of patients distress and on the efficacy of communication skills training for physicians and nurses. He is the author of numerous research papers and of a recent book entitled “ Psycho-oncologie, Concepts Théoriques et Interventions Cliniques” (Elsevier, 2019). He is also the founding member and member of numerous scientific societies.|
|Room||G (1st floor)|
|Target||Clinical psychologists, psychiatrists, social workers, nurses, oncologists, palliative care and hospice clinicians, medical students, psychology students, physicians in training (Psychiatry trainees/fellows; palliative care trainees/fellows, oncology trainees/fellows). This workshop would also be of interest to researchers of all disciplines who are interested in the issue of discussion and of communication in end of life care.|
|Abstract||This one day experiential workshop provides an overview of common clinical challenges in end-of-life care and an introduction to the issue of improving health care professionals communication skills in this area of clinical practice. Useful basic communication skills will be briefly recalled. Participants will be introduced to the main components of advanced communication skills, which may be used in the highly emotional contexts of end of life care and in addressing common difficult clinical encounters. Teaching methods designed to improve communication skills will then be described: techniques (learner-centered, skills-focused, practice-oriented) will be discussed. The usefulness of role-play and immediate feed-back will be emphasized. Effective manualized training programs that have been tested in randomized controlled studies conducted in Brussels for physicians and nurses will be presented. During the workshop participants will have the opportunity to test the type of role-playing exercises utilized in these studies. In addition, a detailed description of these studies and the content of training sessions tested will be provided.|
|18. How should Clinician-Rated Clinical Outcome Assessments (COAs) be developed and used in oncology research and clinical practice?|
|By Katharina Vogt & Georgina Jones|
|Biography||Professor Georgina Jones is a Professor of Health Psychology at Leeds Beckett University. Her research uses both quantitative and qualitative research methods and focuses on quality of life measurement, psychometrics, decision-making and questionnaire development (with a special focus on women's health). She has developed a number of Patient-reported Clinical Outcome Measures. Georgina is internationally recognized as an expert in COA development and psychometrics.
Kathy Vogt is a Lecturer in Health Psychology at the University of Huddersfield; she is also a mixed-methods psychologist. For the past three years, she has worked closely with Professor Georgina Jones on the development of a Clinician-Rated Clinical Outcome Assessment for Wolf-Hirschhorn syndrome, a rare but severe genetic illness. She has published in the areas of health-related quality of life, psycho-oncology and rare genetic illness.
|Room||H (1st floor)|
|Target||Researchers (ECRs encouraged) & clinicians interested in developing their skills in the development of COAs for oncology research and clinical practic.|
|Goal||1. Introduction to different types of Clinical Outcome Assessments, their importance and benefits for research and clinical practice
2. How-to: A step-by-step approach to developing a Clinician-Rated Clinical Outcome Assessment for use in research and clinical practice
3. Developing ideas for research utilizing Clinician-Rated Clinical Outcome Measures (Study design + application)
|Abstract||In clinical practice, there is a high prevalence of discrepancies between patients, their caregivers & treating health care professionals as to what constitutes treatment priorities, indicators of health status or health-related quality of life. The development and subsequent use of Clinical Outcome Assessments (COAs) can bridge these discrepancies.
Clinician-Rated Outcome Assessments (ClinROs) are COAs that are completed by clinicians, and are thus an alternative to Patient-reported Outcome Measures. ClinRos can offer valuable insights into the health-related quality of life, functioning and health status of patients; and are especially beneficial for patients with rare diseases, patients in palliative care and patients whose ability to express themselves is compromised. Outcomes research has long utilized and recognized the benefits of COAs, especially for clinical trials. However, in clinical practice/care, COAs are still under-utilized.
COA /ClinRO development is iterative, complex and challenging; requiring multi-step processes. This workshop will give an overview of different COAs, their benefits/limitations and a step-by-step overview of their development for both research and clinical practice (drawing on guidance from the FDA, ISPOR & COSMIN). This workshop will highlight the importance of incorporating COAs, especially ClinRos, into routine clinical care in Oncology. In addition, gaps in the guidance in regard to COA development for rare diseases are discussed and alternative methodological approaches are suggested.
|19. Managing fear of cancer recurrence in cancer survivors with individual or group therapy|
|By Sophie Lebel, Christine Maheu, Phyllis Butow, Louise Sharpe & Jane Turner|
|Biography||Professor Sophie Lebel is a clinical psychologist with a focus on cancer survivorship and Psychosocial interventions. She has contributed to the definition and measurement of FCR and clinical FCR, validated a blended model of FCR, and co-developed FORT with Dr. Maheu. She was the recipient in 2015 of the CAPO early career award and is former chair of the FCR SIG with IPOS.
Christine Maheu is an Associate Professor at the Ingram School of Nursing, McGill University. Dr. Maheu’s research interests include testing cancer survivorship interventions. She has co-developed the FORT intervention with Dr. Lebel. For her research work in psychosocial care, Dr. Maheu received excellence awards in nursing research (2013, 2015, 2016) from Ovarian Cancer Canada, the Canadian Association of Nurses In Oncology, and the Association Québécoise desinfirmières en oncologie (AQIO) Quebec Association of Nurses in Oncology. Dr. Maheu is the recipient of a junior 2 FRQ-S career award.
Professor Phyllis Butow has worked for over 25 years in Psycho-Oncology. Originally trained as a clinical psychologist, Prof Butow has focused her career on research in doctor-patient communication, and cancer patient and carer support and empowerment. Prof Butow has received many awards for her work, including the IPOS Bernard Fox Award in 2009. Prof. Butow led the research team which evaluated ConquerFear in Australia, and is currently working on several projects adapting and extending ConquerFear for other settings and Formats.
Professor Jane Turner is a consultation-liaison psychiatrist who has worked for over 25 years in oncology. She has extensive experience in medical education and communication skills training and has taken a leading role in Australia in developing psychosocial clinical practice guidelines. Her research focuses on models of care to build psychosocial capacity including training of front-line health professionals. She was an investigator on the ConquerFear study and has presented many workshops to train health professionals in this model.
Professor Louise Sharpe is a clinical psychologist with expertise in cognitive behavioural treatments (CBT) for patients coping with chronic physical illness. She has 30 years of experience in developing treatment programs for novel indications in a range of health conditions and testing their efficacy in randomised controlled trials. She was an investigator on the ConquerFear study. She has received distinguished career awards from the Australian Psychological Society and Australian Association for Cognitive Behaviour Therapy for her contributions to clinical psychology and the practice of CBT.
|Room||Room 510 (5th floor)|
|Target||Health professionals who work with oncology patients during treatment and survivorship (including doctors, nurses, psychologists, psychiatrists and social workers.|
|Goal||1. The attendee shall be able to describe two theoretical frameworks for FCR
2. The attendee shall be able to describe and deliver methods to reduce FCR, including cognitive restructuring, attention training, mindfulness training, awareness and challenging of meta-cognitions about worry, exposure to worst fears, education and encouragement of appropriate levels of screening and monitoring for cancer recurrence
|Abstract||This workshop will focus on the most frequently cited unmet need of cancer survivors – fear of cancer recurrence (FCR). FCR is present to some extent in the majority of people who survive cancer, however this can be more severe for up to 49% of survivors. FCR can be persistent and disabling and lead to difficulty making future plans and over-screening and over-use of medical services. Fortunately, several trials of evidence-based and theoretically supported therapies have been successfully completed in the past 5 years. This workshop will provide a review of the frameworks of two of these recent therapies (the ConquerFear and FORT studies) for understanding FCR. These therapies (one face-to-face, the other a group face-to-face intervention) combine elements of the Self-Regulatory Executive Function (S-
1 e.g. psychologists, social workers…
REF) model, Relational Frame Theory and Self Regulation Theory (ConquerFear) and Cognitive Behavioral Therapy and Existential Therapy (FORT). The content and exercises of these two therapies will be presented in detail. Practical strategies to implement these therapies will be demonstrated and practiced in the workshop. Patient handouts, relevant papers, and frameworks will be provided to workshop attendees.